Tango Therapeutics, Inc.
TNGX
$25.60
-$0.05-0.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.59% | -17.46% | -343.95% | 140.88% | 2.57% |
| Total Depreciation and Amortization | -8.21% | -3.34% | -13.69% | -11.20% | 0.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.61% | 73.40% | -12.59% | 2.51% | -9.35% |
| Change in Net Operating Assets | 91.32% | -515.45% | 104.41% | -955.62% | 48.52% |
| Cash from Operations | 12.39% | -49.27% | 3.99% | 15.24% | 12.42% |
| Capital Expenditure | -- | -- | -47.02% | 75.80% | -1,123.53% |
| Sale of Property, Plant, and Equipment | 900.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,729.85% | 107.11% | -384.49% | 173.69% | -43.22% |
| Cash from Investing | -4,728.68% | 107.10% | -385.86% | 182.97% | -45.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 736.82% | -63.36% | 8,534.87% | 337.35% | 28,950.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 82.31% | -1,391.67% | -- | -- | -- |
| Cash from Financing | 742.33% | -63.60% | 8,533.45% | 337.35% | 28,950.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 316.06% | -16.35% | 182.92% | 199.51% | -72.64% |